Dan Brennan
Stock Analyst at TD Cowen
(4.32)
# 379
Out of 5,050 analysts
121
Total ratings
55.32%
Success rate
15.93%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $345 → $390 | $371.69 | +4.93% | 4 | Nov 5, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $74 → $90 | $66.18 | +35.99% | 7 | Nov 4, 2025 | |
| MYGN Myriad Genetics | Maintains: Hold | $8 → $9 | $6.30 | +42.86% | 2 | Nov 4, 2025 | |
| BRKR Bruker | Maintains: Hold | $40 → $42 | $39.93 | +5.18% | 2 | Nov 4, 2025 | |
| ILMN Illumina | Maintains: Hold | $110 → $115 | $121.90 | -5.66% | 13 | Oct 31, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $612 → $654 | $572.41 | +14.25% | 13 | Oct 23, 2025 | |
| DHR Danaher | Maintains: Buy | $250 → $260 | $209.94 | +23.84% | 6 | Oct 22, 2025 | |
| A Agilent Technologies | Maintains: Buy | $150 → $162 | $146.74 | +10.40% | 13 | Oct 14, 2025 | |
| GH Guardant Health | Maintains: Buy | $63 → $72 | $96.72 | -25.56% | 3 | Sep 25, 2025 | |
| NEO NeoGenomics | Maintains: Buy | $10 → $12 | $10.08 | +19.05% | 7 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $14.79 | +1.42% | 1 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $25.61 | +24.95% | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $110 | $139.73 | -21.28% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $2.5 | $2.87 | -12.89% | 4 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $74 | $71.56 | +3.41% | 2 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $175 | $199.57 | -12.31% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $250 | $168.05 | +48.77% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $141 → $144 | $90.78 | +58.63% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $11.55 | +168.40% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $40.03 | +27.40% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $56 | $7.73 | +624.45% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $15.25 | +109.84% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $166.13 | +228.66% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $4.49 | +55.90% | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.76 | +752.27% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $159.14 | +45.78% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,439.35 | -38.86% | 3 | Oct 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $90 | $92.31 | -2.50% | 2 | Oct 5, 2016 |
Waters
Nov 5, 2025
Maintains: Hold
Price Target: $345 → $390
Current: $371.69
Upside: +4.93%
Exact Sciences
Nov 4, 2025
Maintains: Buy
Price Target: $74 → $90
Current: $66.18
Upside: +35.99%
Myriad Genetics
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $9
Current: $6.30
Upside: +42.86%
Bruker
Nov 4, 2025
Maintains: Hold
Price Target: $40 → $42
Current: $39.93
Upside: +5.18%
Illumina
Oct 31, 2025
Maintains: Hold
Price Target: $110 → $115
Current: $121.90
Upside: -5.66%
Thermo Fisher Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $612 → $654
Current: $572.41
Upside: +14.25%
Danaher
Oct 22, 2025
Maintains: Buy
Price Target: $250 → $260
Current: $209.94
Upside: +23.84%
Agilent Technologies
Oct 14, 2025
Maintains: Buy
Price Target: $150 → $162
Current: $146.74
Upside: +10.40%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $63 → $72
Current: $96.72
Upside: -25.56%
NeoGenomics
Sep 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $10.08
Upside: +19.05%
Aug 6, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $14.79
Upside: +1.42%
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $25.61
Upside: +24.95%
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $139.73
Upside: -21.28%
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $2.87
Upside: -12.89%
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $71.56
Upside: +3.41%
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $199.57
Upside: -12.31%
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $168.05
Upside: +48.77%
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $90.78
Upside: +58.63%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $11.55
Upside: +168.40%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $40.03
Upside: +27.40%
May 13, 2024
Initiates: Buy
Price Target: $56
Current: $7.73
Upside: +624.45%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $15.25
Upside: +109.84%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $166.13
Upside: +228.66%
May 31, 2023
Initiates: Outperform
Price Target: $7
Current: $4.49
Upside: +55.90%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.76
Upside: +752.27%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $159.14
Upside: +45.78%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,439.35
Upside: -38.86%
Oct 5, 2016
Maintains: Buy
Price Target: $78 → $90
Current: $92.31
Upside: -2.50%